Overview
At Triplebar, we’ve miniaturized hypothesis free evolutionary design and test cycles into a proprietary, ultra high-throughput screening microfluidics platform to accelerate direct discovery of functional antibodies in a fraction of the time and cost of industry best in class methodologies while generating incredibly large datasets on antibody function to train AI & machine learning algorithms.